SCHEMBL6567929

SCHEMBL6567929

COC(=O)c1cc(N)ccc1OC(c1ccc(Cl)cc1)c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.40
GAA P10253 2/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HPGD P15428 3/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PYGL P06737 1/20 0.37
IDO1 P14902 2/20 0.36
TDO2 P48775 2/20 0.36
IDO2 Q6ZQW0 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.35
PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565892 0.93 IDO1 (0.44) ABL1GAAHPGDLMNAKDM4E
SCHEMBL6567926 0.92 HPGD (0.42) GAASLC6A4SLC6A3HPGDLMNA
SCHEMBL6567822 0.89 ABL1 (0.39) ABL1GAASLC6A4SLC6A3HPGD
SCHEMBL6567751 0.89 CFTR (0.42) GAAHPGDLMNAKDM4EALDH1A1
SCHEMBL6565805 0.89 ABL1 (0.44) ABL1GAASLC6A4SLC6A3HPGD
SCHEMBL6566010 0.88 IDO1 (0.48) ABL1GAAHPGDLMNAKDM4E
SCHEMBL6567993 0.83 RORC (0.44) HPGDLMNAKDM4EALDH1A1HTT
SCHEMBL6564439 0.83 ALDH1A1 (0.43) ABL1GAASLC6A4SLC6A3HPGD
SCHEMBL6566566 0.83 ABL1 (0.39) ABL1GAASLC6A4SLC6A3HPGD
SCHEMBL6714679 0.82 IDO1 (0.48) GAAHPGDKDM4EALDH1A1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 ABL1 2094/4885GAA 3305/4885SLC6A4 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.